Autopsy report · NCT03323424

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

“No patient enrolled during the authorized period”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Institut de Cancérologie de la Loire

Sponsor type

University, hospital or other

Conditions

Metastatic Breast Cancer; Metastatic Colorectal Cancer; Metastatic Head and Neck Cancer

Interventions

Systemic treatment + Stereotactic Body Radio-Therapy (SBRT); Systemic treatment

Participants

0

Sites

6

Countries

France

Trials that died the same way

• Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder
  “patient did not enroll” (79% match in meaning)
• QLESP Block in Hip Surgery
  “No patients enrolled” (78% match in meaning)
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
  “No eligible patient was enrolled.” (78% match in meaning)
• Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
  “did not enroll a patient” (78% match in meaning)
• Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
  “no patient enrolled.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.